Related Experiment Video
Updated: Jun 6, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication
Casey R Dorr1, Sergiy Yemets, Oksana Kolomitsyna
1University of Minnesota, Institute for Molecular Virology, 18-242 Moos Tower, 525 Delaware St SE, Minneapolis, MN 55455, United States.
Bioorganic & Medicinal Chemistry Letters
|November 19, 2010
Summary
Certain triterpene derivatives show potent anti-HIV-1 activity by inhibiting a late stage of virus replication, specifically targeting virus maturation. These compounds offer potential for new antiviral therapies.
Area of Science:
- Natural Product Chemistry
- Virology
- Medicinal Chemistry
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) remains a global health challenge.
- Developing novel antiviral agents targeting different stages of the HIV-1 lifecycle is crucial.
- Triterpenes are a diverse class of natural products with a wide range of biological activities.
Purpose of the Study:
- To evaluate the anti-HIV-1 activity of various triterpene derivatives.
- To assess the cellular toxicity of these compounds.
- To identify specific triterpene structures with promising antiviral potential.
Main Methods:
- Synthesis and characterization of triterpene derivatives.
- In vitro anti-HIV-1 assays to determine antiviral activity.
- Cellular toxicity assays (e.g., MTT assay) to evaluate safety profiles.
Main Results:
- Several triterpene derivatives, including betulinic aldehyde, betulinic nitrile, and morolic acid derivatives, exhibited significant anti-HIV-1 activity.
- These active compounds demonstrated inhibition of a late stage in the HIV-1 replication cycle.
- Preliminary toxicity assessments indicated a potential therapeutic window for some derivatives.
Conclusions:
- Triterpene derivatives represent a promising class of compounds for developing new anti-HIV-1 therapeutics.
- The identified derivatives likely interfere with HIV-1 maturation, a critical step for viral infectivity.
- Further investigation into the mechanism of action and optimization of these triterpene derivatives is warranted.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...